The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRolls-Royce Regulatory News (RR.)

Share Price Information for Rolls-Royce (RR.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 418.10
Bid: 416.80
Ask: 417.00
Change: 11.60 (2.85%)
Spread: 0.20 (0.048%)
Open: 412.20
High: 418.10
Low: 408.50
Prev. Close: 406.50
RR. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Feb 2018 10:07

RNS Number : 7681D
Rolls-Royce Holdings plc
02 February 2018
 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Rolls-Royce Holdings plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

X

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

ValueAct Capital Management, LLC; ValueAct Capital

Management, L.P.; ValueAct Holdings GP, LLC; ValueAct

Holdings, L.P. (collectively "ValueAct Indirect Holders")

ValueAct Capital Master Fund, L.P.; ValueAct Co-Invest Master Fund, L.P.; ValueAct Capital International Fund A, L.P.

4. Full name of shareholder(s)  (if different from 3.):iv

ValueAct Capital Master Fund, L.P.

ValueAct Co-Invest Master Fund, L.P.

ValueAct Capital International Fund A, L.P.

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

31 January 2018

6. Date on which issuer notified:

01 February 2018

7. Threshold(s) that is/are crossed orreached: vi, vii

11%

 

 

 

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

ValueAct Indirect

Holders Ordinary

Shares

202,466,180

202,466,180

202,466,180

10.94%

ValueAct Capital

Master Fund, L.P.

Ordinary Shares

185,250,952

185,250,952

185,250,952

185,250,952

10.01%

ValueAct Co-Invest Master Fund, L.P.

Ordinary Shares

4,199,671

4,199,671

4,199,671

4,199,671

0.23%

ValueAct Capital International Fund A, L.P.

Ordinary Shares

13,015,557

13,015,557

13,015,557

13,015,557

0.7%

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

202,466,180

10.94%

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

185,250,952 ordinary shares are held by ValueAct Capital Master Fund, L.P. 4,199,671 ordinary shares are held by ValueAct Co-Invest Master Fund, L.P. 13,015,557 ordinary shares are held by ValueAct Capital International Fund A, L.P. VA Partners I, LLC is the general partner of ValueAct Capital Master Fund, L.P., ValueAct Co-Invest Master Fund, L.P., and ValueAct Capital International Fund A, L.P. ValueAct Capital Management, L.P. is the manager of ValueAct Capital Master Fund, L.P., ValueAct Co-Invest Master Fund, L.P., and ValueAct Capital International Fund A, L.P. ValueAct Capital Management, LLC is the general partner of ValueAct Capital Management, L.P. ValueAct Holdings, L.P. is the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC, and is the majority owner of the membership interests of VA Partners I, LLC. ValueAct Holdings GP, LLC is the General Partner of ValueAct Holdings, L.P.

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

Sonia M. Muscatine

15. Contact telephone number:

+001 415-362-3700

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUURRRWVAURAR
Date   Source Headline
27th Jun 202312:00 pmRNSAdmission of Shares
8th Jun 20232:00 pmRNSDirector/PDMR Shareholding
30th May 202312:00 pmRNSDirector/PDMR Shareholding
19th May 202312:00 pmRNSDirector/PDMR Shareholding
11th May 20232:07 pmRNSResult of AGM
11th May 20239:14 amRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSAGM Statement and Trading Update
10th May 20234:00 pmRNSDirectorate change & withdrawal of AGM resolution
28th Apr 20233:44 pmRNSDirector/PDMR Shareholding
14th Apr 20239:30 amRNSDirector/PDMR Shareholding
11th Apr 20231:00 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSDirectorate Change
29th Mar 20239:34 amRNSDirector/PDMR Shareholding
21st Mar 20233:03 pmRNSDirector/PDMR Shareholding
17th Mar 20233:00 pmRNSDirector/PDMR Shareholding
10th Mar 20232:35 pmRNSDirector/PDMR Shareholding
8th Mar 20233:39 pmRNSDirector/PDMR Shareholding
2nd Mar 20239:00 amRNSAnnual Report 2022 and Annual General Meeting 2023
1st Mar 20235:05 pmRNSHolding(s) in Company
28th Feb 20234:17 pmRNSDirector/PDMR Shareholding
24th Feb 202312:00 pmRNSDirector/PDMR Shareholding
23rd Feb 20237:00 amRNS2022 Full Year Results
10th Feb 20239:09 amRNSDirector Declaration
9th Feb 20239:30 amRNSDirector/PDMR Shareholding
9th Feb 20237:00 amRNSDirectorate Change
31st Jan 20239:30 amRNSDirector/PDMR Shareholding
11th Jan 20233:50 pmRNSDirector/PDMR Shareholding
22nd Dec 202211:05 amRNSDirector/PDMR Shareholding
21st Dec 20229:37 amRNSDirectorate Change
8th Dec 20222:37 pmRNSDirector/PDMR Shareholding
5th Dec 20224:04 pmRNSDirector/PDMR Shareholding
29th Nov 20229:30 amRNSDirector/PDMR Shareholding
18th Nov 202210:07 amRNSHolding(s) in Company
14th Nov 202210:00 amRNSHolding(s) in Company
10th Nov 20229:15 amRNSHolding(s) in Company
9th Nov 20222:40 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTrading Statement
31st Oct 20229:30 amRNSDirector/PDMR Shareholding
18th Oct 20222:45 pmRNSDirector Declaration
13th Oct 20223:15 pmRNSHolding(s) in Company
10th Oct 20225:11 pmRNSDirector/PDMR Shareholding
10th Oct 20229:30 amRNSHolding(s) in Company
5th Oct 20225:05 pmRNSHolding(s) in Company
28th Sep 202211:00 amRNSDirector/PDMR Shareholding
26th Sep 20227:00 amRNSChange of Registrar
20th Sep 202211:45 amRNSExecutive Team Change
15th Sep 202210:54 amRNSRolls-Royce Completes Sale of ITP Aero
12th Sep 20229:00 amRNSHolding(s) in Company
7th Sep 20223:03 pmRNSDirector/PDMR Shareholding
30th Aug 202211:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.